Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_assertion description "[The African American Study of Kidney Disease and Hypertension provided evidence that an angiotensin-converting enzyme inhibitor-based treatment program is more beneficial than calcium channel blockers and beta blockers in reducing the progression of renal failure in blacks with hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_assertion evidence source_evidence_literature NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_assertion SIO_000772 14688494 NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_assertion wasDerivedFrom befree-2016 NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_assertion wasGeneratedBy ECO_0000203 NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.
- befree-2016 importedOn "2016-02-19" NP425565.RAdEk8xRlhJmfFaxc0W-FH3qNY-ZcIVXFBoaytKBXo-4A130_provenance.